Re: Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms that Castration-Resistant Prostrate Cancer Commonly Remains Hormone Driven

✍ Scribed by Nicholas J. Vogelzang

• Book ID: 113611445
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 87 KB
• Volume: 56
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2009.04.017